Phenotyping and genotyping neuropathic pain

Current Pain and Headache Reports

Volumn 14, Issue 3, 2010, Pages 203-212

  Belfer, Inna ^a,b   Dai, Feng ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Association; Genetic; Neuropathic pain; Phenotype; Psychophysical; Psychosocial

Indexed keywords

CATECHOL METHYLTRANSFERASE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; HLA ANTIGEN; INTERLEUKIN 6; POTASSIUM VOLATAGE GATED CHANNEL SUBFAMILY S MEMBER 1; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ALLELE; ANALYTICAL ERROR; AUTONOMIC NERVOUS SYSTEM; BIOSTATISTICS; BRIEF PAIN INVENTORY; CLINICAL ASSESSMENT; FOLLOW UP; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MARKER; GENETIC RISK; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE MAP; HUMAN; INSTRUMENT VALIDATION; MCGILL PAIN QUESTIONNAIRE; MEDICAL HISTORY; MISSENSE MUTATION; MOLECULAR DYNAMICS; MULTIVARIATE ANALYSIS; NEUROPATHIC PAIN; NEUROPATHOLOGY; PAIN ASSESSMENT; PHENOTYPE; POPULATION RESEARCH; PROCESS DESIGN; PROTEIN FUNCTION; PSYCHOPHYSIOLOGY; REVIEW; SAMPLE SIZE; SENSITIVITY AND SPECIFICITY; SHORT FORM 36; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL PSYCHOLOGY; VISUAL ANALOG SCALE; CLASSIFICATION; GENETIC PREDISPOSITION; GENETICS; NEURALGIA; PSYCHOLOGY;

GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; NEURALGIA; PHENOTYPE;

EID: 77956395246     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-010-0110-1     Document Type: Review

References (82)

1. IASP Task Force on Taxonomy: Part III: Pain terms, a current list with definitions and notes on usage. Classification of Chronic Pain, second edition. Merskey H, Bogduk N editors. Seattle, WA: IASP Press; 1994:209-214.
2. Treede RD, Jensen TS, Campbell JN, et al.: Neuropathic pain: Redefinition and a grading system for clinical use and research purposes. Neurology 2008, 70:1630-1635.
3. Woolf CJ, Mannion RJ: Neuropathic pain: Aetiology, symptoms, mechanisms, and management. Lancet 1999, 353:1959-1964.
4. Woolf CJ: Dissecting out mechanisms responsible for peripheral neuropathic pain: implications for diagnosis and therapy. Life Sci 2004, 74:2605-2610.
5. Latremoliere A,Woolf CJ: Central sensitization: A generator of pain hypersensitivity by central neural plasticity. J Pain 2009, 10:895-926. This article reviews the major triggers that initiate and maintain central sensitization in healthy individuals in response to nociceptor input and in patients with neuropathic pain.
6. O'Connor AB, Dworkin RH: Treatment of neuropathic pain: An overview of recent guidelines. Am J Med 2009,122(Suppl 10): S22-S32.
7. Jensen MP, Chodroff MJ, Dworkin RH: The impact of neuropathic pain on health-related quality of life. Neurology 2007, 68:1178-1182.
8. Siniscalco D, Rossi F, Maione S: Molecular approaches for neuropathic pain treatment. Curr Med Chem 2007, 14:1783-1787. This review provides data on epidemiology, social life, and treatment challenges associated with neuropathic pain.
9. Mogil JS, Max MB (2005) The genetics of pain. In: Koltzenburg M, McMahon SB (eds) Wall and Melzack's textbook of pain, 5th edn. Elsevier Churchill Livingstone, London, pp 159-174.
10. Lacroix-Fralish ML, Mogil JS: Progress in genetic studies of pain and analgesia. Annu Rev Pharmacol Toxicol 2009, 49:97-121.
11. Zubieta JK, Heitzeg MM, Smith YR, et al.: COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003, 299:1240-1243.
12. Diatchenko L, Nackley AG, Tchivileva IE, et al.: Genetic architecture of human pain perception. Trends Genet 2007, 23:605-613. This comprehensive review discusses the discoveries in genetic studies of human pain and proposes how rare, deleterious variants and common polymorphisms mediate pain perception and clinical pain phenotypes.
13. Norbury TA, MacGregor AJ, Urwin J, et al.: Heritability of responses to painful stimuli in women: A classical twin study. Brain 2007, 130:3041-3049.
14. Lohmueller KE, Pearce CL, Pike M, et al.: Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003, 33:177-182.
15. Risch N, Merikangas K: The future of genetic studies of complex human diseases. Science 1996, 273:1516-1517.
16. Enoch MA, Shen PH, Xu K, et al.: Using ancestry-informative markers to define populations and detect population stratification. J Psychopharmacol 2006, 20(Suppl 4):19-26.
17. Liem EB, Joiner TV, Tsueda K, Sessler DI: Increased sensitivity to thermal pain and reduced subcutaneous lidocaine efficacy in redheads. Anesthesiology 2005, 102:509-514.
18. Binkley CJ, Beacham A, Neace W, et al.: Genetic variations associated with red hair color and fear of dental pain, anxiety regarding dental care and avoidance of dental care. J Am Dent Assoc 2009, 140:896-905.
19. Baron R, Tölle TR: Assessment and diagnosis of neuropathic pain. Curr Opin Support Palliat Care 2008, 2:1-8. This article describes tools for the comprehensive assessment of neuropathic pain patients in clinic.
20. Haanpää ML, Backonja MM, Bennett MI, et al.: Assessment of neuropathic pain in primary care. Am J Med 2009,122(Suppl 10): S13-S21. This review provides guidance in understanding and identifying the neuropathic contribution to pain presenting in primary care, assessing its severity, and establishing a rational treatment plan.
21. Naylor MR, Helzer JE, Naud S, Keefe FJ: Automated telephone as an adjunct for the treatment of chronic pain: A pilot study. J Pain 2002, 3:429-438; web-based scales or with mailed questionnaires.
22. Rog DJ, Nurmikko TJ, Friede T, Young CA: Validation and reliability of the Neuropathic Pain Scale (NPS) in multiple sclerosis. Clin J Pain 2007, 23:473-481.
23. Freynhagen R, Baron R, Gockel U, Tölle TR: PainDETECT: A new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 2006, 22:1911-1920.
24. Zelman DC, Gore M, Dukes E, et al.: Validation of a modified version of the Brief Pain Inventory for painful diabetic peripheral neuropathy. J Vasc Nurs 2005, 23:97-104.
25. Bennett M: The LANSS Pain Scale: The Leeds assessment of neuropathic symptoms and signs. Pain 2001, 92:147-157.
26. Bennett MI, Smith BH, Torrance N, Potter J: The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain 2005, 6:149-158.
27. Krause SJ, Backonja MM: Development of a neuropathic pain questionnaire. Clin J Pain 2003, 19:306-314.
28. Backonja MM, Krause SJ: Neuropathic pain questionnaire-short form. Clin J Pain 2003, 19:315-316.
29. Bouhassira D, Attal N, Alchaar H, et al.: Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005, 114:29-36.
30. Portenoy R: Development and testing of a neuropathic pain screening questionnaire: ID Pain. Curr Med Res Opin 2006, 22:1555-1565.
31. Bennett MI, Attal N, Backonja MM, et al.: Using screening tools to identify neuropathic pain. Pain 2007, 127:199-203.
32. Chan KS, Chen WH, Gan TJ, et al.: Development and validation of a composite score based on clinically meaningful events for the opioid-related symptom distress scale. Qual Life Res 2009, 18:1331-1340.
33. Gärtner R, Jensen MB, Nielsen J, et al.: Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA 2009, 302:1985-1992.
34. Scholz J, Mannion RJ, Hord DE, et al.: A novel tool for the assessment of pain: validation in low back pain. PLoS Med 2009, 6:e1000047. This article presents a novel method of identifying pain subtypes that reflect underlying pain mechanisms. Beyond diagnostic utility, this tool may offer a unique opportunity to improve targeted analgesic treatment.
35. Graff-Radford SB, Kames LD, Naliboff BD: Measures of psychological adjustment and perception of pain in postherpetic neuralgia and trigeminal neuralgia. Clin J Pain 1986, 2:255-258.
36. Benrud-Larson LM, Wegener ST: Chronic pain in neurorehabilitation populations: Prevalence, severity and impact. NeuroRehabilitation 2000, 14:127-137.
37. Atlas SJ, Deyo RA, Keller RB, et al.: The Maine Lumbar Spine Study, Part II. 1-year outcomes of surgical and nonsurgical management of sciatica. Spine 1996, 21:1777-1786.
38. Zelman DC, Brandenburg NA, Gore M: Sleep impairment in patients with painful diabetic peripheral neuropathy. Clin J Pain 2006, 22:681-685.
39. Solidaki E, Chatzi L, Bitsios P, et al.: Work-related and psychological determinants of multisite musculoskeletal pain. Scand J Work Environ Health 2010, 36:54-61.
40. Haythornthwaite JA, Benrud-Larson LM: Psychological assessment and treatment of patients with neuropathic pain. Curr Pain Headache Rep 2001, 5:124-129.
41. Beck AT, Ward CH, Mendelson M, et al.: An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
42. Radloff LS: The CES-D scale: A self report depression scale for research in the general population. Applied Psychol Measures 1977, 1:385-401.
43. Spielberger CD, Gorsuch RL, Lushene R, et al.: Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1983.
44. McCracken LM, Zayfert C, Gross RT: The Pain Anxiety Symptoms Scale: Development and validation of a scale to measure fear of pain. Pain 1992, 50:67-73.
45. Derogatis L: The SCL-90R: Administration, Scoring, and Procedures Manual. Towson, MD: Clinical Psychometric Research; 1983.
46. Tait RC, Chibnall JT, Krause S: The Pain Disability Index: Psychometric properties. Pain 1990, 40:171-182.
47. Kerns RD, Turk DC, Rudy TE: The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain 1985, 23:345-356.
48. Ware J Jr, Kosinski M, Keller SD: A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Med Care 1996, 34:220-233.
49. Sullivan MJ, Lynch ME, Clark AJ. Dimensions of catastrophic thinking associated with pain experience and disability in patients with neuropathic pain conditions. Pain. 2005, 113:310-315.
50. Boothby JL, Thorn BE, Stroud MW, Jensen MP: Coping with pain. In Psychosocial Factors in Pain. Edited by Gatchel RJ, Turk DC. New York: Guilford Press; 1999:343-359.
51. Rosenstiel AK, Keefe FJ: The use of coping strategies in chronic low back pain patients: Relationship to patient characteristics and current adjustment. Pain 1983, 17:33-44.
52. Jensen MP, Turner JA, Romano JM, Strom SE: The Chronic Pain Coping Inventory: Development and preliminary validation. Pain 1995, 60:203-216.
53. Clark MR, Heinberg LJ, Haythornthwaite JA, et al.: Psychiatric symptoms and distress differ between patients with postherpetic neuralgia and peripheral vestibular disease. J Psychosom Res 2000, 48:51-57.
54. Freynhagen R, Rolke R, Baron R, et al.: Pseudoradicular and radicular low-back pain-a disease continuum rather than different entities? Answers from quantitative sensory testing. Pain 2008, 135:65-74.
55. Gottrup H, Andersen J, Arendt-Nielsen L, Jensen TS: Psychophysical examination in patients with post-mastectomy pain. Pain 2000, 87:275-284.
56. Backonja MM, Walk D, Edwards RR, et al.: Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalities. Clin J Pain 2009, 25:641-647. This is a concise review of fundamental concepts necessary for understanding the role of QST in the process of eliciting information about sensory abnormalities associated with neuropathic pain and the place of that information in analysis of pain mechanisms.
57. Walk D, Sehgal N, Moeller-Bertram T, et al.: Quantitative sensory testing and mapping: A review of nonautomated quantitative methods for examination of the patient with neuropathic pain. Clin J Pain 2009, 25:632-640. This review provides definitions that help further the use of QST as a diagnostic tool as well as phenotyping tool.
58. Randich A, Maixner W: Interactions between cardiovascular and pain regulatory systems. Neurosci Biobehav Rev 1984, 8:343-367.
59. Diatchenko L, Slade GD, Nackley AG, et al.: Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 2005, 14:135-143.
60. Maixner W, Fillingim R, Kincaid S, et al.: Relationship between pain sensitivity and resting arterial blood pressure in patients with painful temporomandibular disorders. Psychosom Med 1997, 59:503-511.
61. Cardon LR: Genetics. Delivering new disease genes. Science 2006, 314:1403-1405.
62. Thornton-Wells TA, Moore JH, Haines JL: Genetics, statistics and human disease: Analytical retooling for complexity. Trends Genet 2004, 20:640-647.
63. Maletic V, Raison CL: Neurobiology of depression, fibromyalgia and neuropathic pain. Front Biosci 2009, 14:5291-5338. This article synthesizes recent data suggesting that the high rates of comorbidity observed between major depression, fibromyalgia, and neuropathic pain likely result from the fact that these disorders share multiple biological and environmental underpinnings.
64. Buskila D: Genetics of chronic pain states. Best Pract Res Clin Rheumatol 2007, 21:535-547.
65. Solovieva S, Kouhia S, Leino-Arjas P, et al.: Interleukin 1 polymorphisms and intervertebral disc degeneration. Epidemiology 2004, 15:626-633.
66. Noponen-Hietala N, Virtanen I, Karttunen R, et al.: Genetic variations in IL6 associate with intervertebral disc disease characterized by sciatica. Pain 2005, 114:186-194.
67. Sato M, Ohashi J, Tsuchiya N, et al.: Association of HLA.A.* 3303-.B.*4403-DRB1.*1302 haplotype, but not of TNFA promoter and NKp30 polymorphism, with postherpetic neuralgia (PHN) in the Japanese population. Genes Immun 2002, 3:477-481.
68. Lee YS, Kim H, Wu TX, et al.: Genetically mediated interindividual variation in analgesic responses to cyclooxygenase inhibitory drugs. Clin Pharmacol Ther 2006, 79:407-418.
69. Armero P, Muriel C, Santos J, et al.: COMT (Val158Met) polymorphism is not associated to neuropathic pain in a Spanish population. Eur J Pain. 2005, 9:229-232.
70. Anand P: Neurotrophic factors and their receptors in human sensory neuropathies. Prog Brain Res 2004, 146:477-492.
71. Belfer I, Wu T, Kingman A, et al.: Candidate gene studies of human pain mechanisms: Methods for optimizing choice of polymorphisms and sample size. Anesthesiology 2004, 100:1562-1572.
72. Gabriel SB, Schaffner SF, Nguyen H, et al.: The structure of haplotype blocks in the human genome. Science 2002, 296:2225-2229.
73. Cardon LR, Abecasis GR: Using haplotype blocks to map human complex trait loci. Trends Genet 2003, 19:135-140.
74. Pritchard JK, Stephens M, Rosenberg NA, Donnelly P: Association mapping in structured populations. Am J Hum Genet 2000,67:170-181.
75. Smith SB, Fillingim RB, Slade GD, et al.: Candidate genes associate with psychological risk factors for chronic pain in OPPERA, a multi-site population-based cohort study [abstract]. Presented at Society for Neuroscience, 39th Annual Meeting. Chicago, IL; October 17-21, 2009.
76. Max MB, Stewart WF: The molecular epidemiology of pain: A new discipline for drug discovery. Nat Rev Drug Discov 2008, 7:647-658. This great review discusses how the molecular epidemiology approach to study human pain improves our understanding of the pain pathogenesis by identifying specific pathways, molecules, and genes that influence the risk of symptom/syndrome development.
77. Donnelly P: Progress and challenges in genome-wide association studies in humans. Nature 2008, 456:728-731. This article discusses the ability of human genetic association data to provide new routes to understanding the etiology of disease, as well as new footholds on the long and difficult path to better treatment and disease prevention.
78. Akey J, Jin L, Xiong M: Haplotypes vs single marker linkage disequilibrium tests: what do we gain? Eur J Hum Genet 2001, 9:291-300.
79. Zaykin DV, Westfall PH, Young SS, et al.: Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 2002, 53:79-91.
80. Li Y, Sung WK, Liu JJ: Association mapping via regularized regression analysis of single-nucleotide-polymorphism haplotypes in variable-sized sliding windows. Am J Hum Genet 2007, 80:705-715.
81. Roeder K, Devlin B, Wasserman L: Improving power in genomewide association studies: weights tip the scale. Genet Epidemiol 2007, 31:741-747.
82. Kavvoura FK, Ioannidis JP: Methods for meta-analysis in genetic association studies: A review of their potential and pitfalls. Hum Genet 2008, 123:1-14.